Ninggang Zhang

机构：Shanxi Medical University, Shanxi Provincial Cancer Hospital

发表论文 20 篇 · 总被引 133 次 · h-index 7

代表论文

• Tumor-Associated Macrophage-Derived Exosomes Promote Progression of Gastric Cancer by Regulating P38MAPK Signaling Pathway and Immune Checkpoint PD-L1 (2021 · Cancer Biotherapy and Radiopharmaceuticals · 被引 26)
• LRG1 Suppresses Migration and Invasion of Esophageal Squamous Cell Carcinoma by Modulating Epithelial to Mesenchymal Transition (2020 · Journal of Cancer · 被引 25)
• Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinoma (2019 · Investigational New Drugs · 被引 21)
• Pyrotinib treatment on HER2-positive gastric cancer cells promotes the released exosomes to enhance endothelial cell progression, which can be counteracted by apatinib (2019 · OncoTargets and Therapy · 被引 20)
• Radiosensitization of HER2-positive esophageal cancer cells by pyrotinib (2020 · Bioscience Reports · 被引 11)
• Case report: Kidney perivascular epithelioid cell tumor treated with anti-VEGFR tyrosine kinase inhibitor and MTOR inhibitor (2022 · Frontiers in Oncology · 被引 8)